Cargando…

Strategies for selecting/switching chemotherapy and supportive care treatments during COVID‐19 outbreak

Detalles Bibliográficos
Autores principales:	Li, Quan, Hwang, Leon C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404874/ https://www.ncbi.nlm.nih.gov/pubmed/32779851 http://dx.doi.org/10.1002/cam4.3314

Ejemplares similares

Adjusting for treatment switching in the METRIC study shows further improved overall survival with trametinib compared with chemotherapy
por: Latimer, Nicholas R., et al.
Publicado: (2016)

Induction chemotherapy in the treatment of nasopharyngeal carcinoma: Clinical outcomes and patterns of care
por: Gabani, Prashant, et al.
Publicado: (2018)

Trilaciclib prior to chemotherapy reduces the usage of supportive care interventions for chemotherapy‐induced myelosuppression in patients with small cell lung cancer: Pooled analysis of three randomized phase 2 trials
por: Ferrarotto, Renata, et al.
Publicado: (2021)

Automated home monitoring and management of patient‐reported symptoms during chemotherapy: results of the symptom care at home RCT
por: Mooney, Kathi H., et al.
Publicado: (2017)

The effects of an integrated supportive care intervention on quality of life outcomes in outpatients with breast and gynecologic cancer undergoing chemotherapy: Results from a randomized controlled trial
por: Klafke, Nadja, et al.
Publicado: (2019)

Lung cancer costs by treatment strategy and phase of care among patients enrolled in Medicare
por: Sheehan, Deirdre F., et al.
Publicado: (2018)

Chemotherapy treatments, costs of care, and survival for patients diagnosed with small cell lung cancer: A SEER‐Medicare study
por: Shao, Changxia, et al.
Publicado: (2019)

Older cancer patients and COVID‐19 outbreak: Practical considerations and recommendations
por: Brunello, Antonella, et al.
Publicado: (2020)

Treatment times in breast cancer patients receiving neoadjuvant vs adjuvant chemotherapy: Is efficiency a benefit of preoperative chemotherapy?
por: Melchior, Nicole M., et al.
Publicado: (2020)

Venous thromboembolism during preoperative chemotherapy in the CRITICS gastric cancer trial
por: Slagter, Astrid E., et al.
Publicado: (2020)

COVID‐19 outbreak: An experience to reappraise the role of hospital at home in the anti‐cancer drug injection
por: Mittaine‐Marzac, Bénédicte, et al.
Publicado: (2021)

Crizotinib vs platinum‐based chemotherapy as first‐line treatment for advanced non‐small cell lung cancer with different ROS1 fusion variants
por: Xu, Haiyan, et al.
Publicado: (2020)

Risk stratification for lung adenocarcinoma on EGFR and TP53 mutation status, chemotherapy, and PD‐L1 immunotherapy
por: Wu, Chih‐Hsun, et al.
Publicado: (2019)

Metronomic combination chemotherapy using everolimus and etoposide for the treatment of non‐Hodgkin lymphoma
por: Wu, Ke, et al.
Publicado: (2019)

Personalized Risk–Benefit Ratio Adaptation of Breast Cancer Care at the Epicenter of COVID‐19 Outbreak
por: Viale, Giulia, et al.
Publicado: (2020)

Diverse patient trajectories during cytotoxic chemotherapy: Capturing longitudinal patient‐reported outcomes
por: Azad, Amee D., et al.
Publicado: (2021)

Characteristics and mechanisms to control a COVID‐19 outbreak on a leukemia and stem cell transplantation unit
por: Greiner, Jochen, et al.
Publicado: (2020)

Rethinking clinical oncology drug research in an era of value‐based cancer care: A role for chemotherapy pathways
por: Hoverman, J. Russell
Publicado: (2020)

Retrospective analysis of systemic chemotherapy and total parenteral nutrition for the treatment of malignant small bowel obstruction
por: Chouhan, Jay, et al.
Publicado: (2015)

The role of chemotherapy in the treatment of stage II nasopharyngeal carcinoma: Retrospective analysis of the national cancer database
por: Ahmed, Zaheer, et al.
Publicado: (2019)

Association between weight gain during adjuvant chemotherapy for early‐stage breast cancer and survival outcomes
por: Schvartsman, Gustavo, et al.
Publicado: (2017)

Utilization of neoadjuvant chemotherapy in high‐risk, node‐negative early breast cancer
por: Prakash, Ipshita, et al.
Publicado: (2022)

Clinical benefit of methotrexate plus vinorelbine chemotherapy for desmoid fibromatosis (DF) and correlation of treatment response with MRI
por: Ingley, Katrina M., et al.
Publicado: (2019)

Phase II trial of S‐1 treatment as palliative‐intent chemotherapy for previously treated advanced thymic carcinoma
por: Okuma, Yusuke, et al.
Publicado: (2020)

Burden of hospitalization in acute lymphoblastic leukemia patients treated with Inotuzumab Ozogamicin versus standard chemotherapy treatment
por: Marks, David I., et al.
Publicado: (2019)

Palliative chemotherapy or best supportive care? A prospective study explaining patients' treatment preference and choice
por: Koedoot, C G, et al.
Publicado: (2003)

Predicting the effect of 5‐fluorouracil–based adjuvant chemotherapy on colorectal cancer recurrence: A model using gene expression profiles
por: Chen, Quan, et al.
Publicado: (2020)

A randomized controlled trial of structured palliative care versus standard supportive care for patients enrolled in phase 1 clinical trials
por: Treasure, Michelle, et al.
Publicado: (2021)

Clinical and demographic characteristics associated with the receipt of chemotherapy treatment among 7951 elderly metastatic colon cancer patients
por: Reese, Emily S, et al.
Publicado: (2013)

Effectiveness of modified hyper‐CVAD chemotherapy regimen in the treatment of adult acute lymphoblastic leukemia: a retrospective experience
por: Jalaeikhoo, Hasan, et al.
Publicado: (2018)

Cost‐effectiveness analysis of pembrolizumab plus chemotherapy with PD‐L1 test for the first‐line treatment of NSCLC
por: Wan, Ning, et al.
Publicado: (2020)

Hematologic toxicity in BRCA1 and BRCA2 mutation carriers during chemotherapy: A retrospective matched cohort study
por: West, Allison H., et al.
Publicado: (2019)

Therapeutic targeting of TGF-β in cancer: hacking a master switch of immune suppression
por: van den Bulk, Jitske, et al.
Publicado: (2021)

Improved outcome of children with relapsed/refractory acute myeloid leukemia by addition of cladribine to re‐induction chemotherapy
por: Ruan, Min, et al.
Publicado: (2021)

Adjuvant treatment combining cellular immunotherapy with chemotherapy improves the clinical outcome of patients with stage II/III gastric cancer
por: Wang, Yizhuo, et al.
Publicado: (2016)

Impact of adjuvant chemotherapy on outcomes in appendiceal cancer
por: Kolla, Bhaskar C., et al.
Publicado: (2020)

Economics of alternative dosing strategies for pembrolizumab and nivolumab at a single academic cancer center
por: Hall, Evan, et al.
Publicado: (2020)

Supportive care for men with prostate cancer: why are the trials not working? A systematic review and recommendations for future trials
por: Moore, Theresa Helen Mazzarello, et al.
Publicado: (2015)

Exploring changes in dietary intake, physical activity and body weight during chemotherapy in women with breast cancer: A Mixed‐Methods Study
por: de Kruif, Anja JThCM, et al.
Publicado: (2021)

A comparison of resource utilization following chemotherapy for acute myeloid leukemia in children discharged versus children that remain hospitalized during neutropenia
por: Getz, Kelly D, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0i50iv5cvjldchi6sl2ei4u9h6